day 1 agenda
12th Global Insight Conference on Breast Cancer | |
Day -1: July(07, 2025) | |
Meeting Hall-I | |
Registrations Open (08:00-08:45) | |
Opening Ceremony (08:45-09:00) | |
Moderator Jessica Burgers, Holy Cross Health, USA |
|
Keynote Talks | |
09:00-09:30 | Title: TFEB is a master regulator of tumor-associated macrophages in breast cancer |
Daping Fan, University Of South Carolina, USA | |
09:30-10:00 | Title: Context-Responsive Nanomedicine in Targeted CRISPR/Cas9 Therapy for Basal Like Breast Cancer |
Dipanjan Pan, The Pennsylvania State University, USA | |
10:00-10:30 | Title: Distinct Tumor Immune Responses to Nanosecond Pulsed Electric Fields (nsPEFs) Determine Immunity |
Stephen Jack Beebe, Old Dominion University, USA | |
Group Photo 10:30-10:45 ---Refreshment Break @ Foyer |
|
SCIENTIFIC SESSION-I Session Chair: Hanna Romanska-Knight, Medical University of Lodz, Poland |
|
10:45-11:05 | Title: Modern Management of the Axilla in Breast Cancer |
Rizzo Monica, Emory University School of Medicine, USA | |
11:05-11:25 | Title: Breast Cancer Screening in the Elderly United States Population: Challenges and Future Considerations |
Jessica Burgers, Holy Cross Health, USA | |
11:25-11:45 | Title: Comparing Narrow and Wide Angle Digital Breast Tomosynthesis |
Tanya W. Moseley, The University of Texas MD Anderson Cancer Center, USA | |
11:45-12:05 | Title: The Molecular Mechanisms behind Advanced Breast Cancer: Metabolic Reprogramming and Alternate Translation |
Columba De La Parra, Lehman College- City University of New York, USA | |
12:05-12:25 | Title: The effect of deuterium depletion on the survival outcomes of cancer patients and recurrence of the disease |
Gábor Somlyai, HYD LLC for Cancer Research and Drug Development, Hungary | |
12:25-12:45 | Title: Anticancer Potential of Black Ginseng Extract in a Breast Cancer Cell Xenograft Mouse Model |
Hye Jin Park, Kangwon National University, South Korea | |
Networking & Panel Discussion | |
12:45-13:45 Lunch Break @ Restaurant | |
SCIENTIFIC SESSION-II Session Chairs: Dipanjan Pan, The Pennsylvania State University, USA & Amy S. Yee, Tufts University School of Medicine, USA |
|
13:45-14:05 | Title: The Wu-Kolassa Estimator in Restricted Mean Survival Time Analysis: Reducing Bias and Enhancing Power in Oncology Survival Studies |
Yaoshi Wu, AstraZeneca, USA | |
14:05-14:25 | Title: The Revolution in Understanding Breast Cancer Recurrences |
Howard Petty, University of Michigan, USA | |
14:25-14:45 | Title: Technological Innovations Enable the 24-hour Discharge of Patients Who Undergo Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction: Safety and Aesthetic Outcomes from A Single-Centre, Prospective Cohort Study |
Zhenggui Du, West China Hospital of Sichuan University, Sofia, China | |
14:45-15:05 | Title: A Precision engineered approach based on modular assembly for in vitro expansion of low-abundance antigen-specific T cells |
Zhangyong Hong, Nankai University, China | |
15:05-15:45 | Title: Can Fraction-B from Catfish Skin be Used Successfully for the Treatment of Breast Cancer and for Healing Wounds Cosmetically After Breast Cancer Surgery? |
Jassim M. H. AlMohammad Ali, Abdullah AlSalem University, Kuwait | |
15:45-16:05 | Title: Postoperative outcomes of minimally-invasive nipple-sparing mastectomy with immediate breast reconstruction versus conventional approach in women with early breast cancer – a single centre experience |
Marc Ong Weijie, Khoo Teck Puat Hospital, Singapore | |
16:05-16:15 Refreshment Break | |
16:15-16:35 | Title: FGF/FGFR-Signaling in response to therapy in triple-positive breast cancer |
Hanna Romanska-Knight, Medical University of Lodz, Poland | |
16:35-16:55 | Title: MEMS-based biochips for electro-thermo-mechanical (ETM) phenotyping of breast biopsy tissues |
Hardik Jeetendra Pandya, Indian Institute of Science, Bangalore, India | |
16:55-17:15 | Title: Hypoxia modulates the XBP1s/HDAC2/EZH2-ΔNp63α axis to promote breast cancer metastasis independent of HIF1α |
Zhixiong Jim Xiao, Sichuan University, China | |
17:15-17:35 | Title: The regulation of the triple-negative breast cancer microenvironment by the CD74/CD84-induced cascade |
Idit Shachar, Weizmannn Institute of Science, Israel | |
Networking & Panel Discussion | |
Day-1 Concludes | |
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org |
day 2 agenda
Day -2: July(08, 2025) | |
Meeting Hall-I | |
Moderator Izabela M?ynarczuk-Bia?y, Warsaw Medical University, Poland |
|
Keynote Talks | |
09:15-09:45 | Title: Radioguided occult lesion localisation for non-palpable breast lesions in combination with radioisotope sentinel lymph node localisation (SNOLL) – 10 year experience of a single centre |
Maged Hussien, Norfolk and Norwich University hospital, United Kingdom | |
09:45-10:15 | Title: Poor oral health and cancer – why does it matter? |
Jukka H. Meurman, University of Helsinki and Helsinki University, Finland | |
10:15-10:45 | Title: The Luminous Pro Series (LPS Pink Luminous Breast), an LED-based technology utilizing patented red light wavelengths between 620–800 nanometers, demonstrated comparable sensitivity and specificity to mammography in detecting breast abnormalities |
Marylin R Dans, Silkprousa, USA | |
10:45-11:00 Refreshment Break | |
SCIENTIFIC SESSION-III Session Chairs: Halina Abramczyk, Lodz University of Technology, Poland & YuTe Liu, Chung Shan Medical University, Taiwan |
|
11:00-11:20 | Title: Identification of Novel Markers for TTK Inhibitor and Taxane Sensitivity in Triple-Negative Breast Cancer |
Lei Duan, Rush University Medical Center, USA | |
11:20-11:40 | Title: In vitro and in vivo effects of A traditional Chinese medicine (TCM) in human breast cancer cells |
YuTe Liu, Chung Shan Medical University, Taiwan | |
11:40-12:00 | Title: Growth inhibitory effect of Leptospermum scoparium (manuka) chloroform extract on breast and liver cancer cell lines |
Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia | |
12:00-12:20 | Title: Prevalence of Epidermal Growth Factors Receptors in Iraqi Patients with Non-Small Cell Lung Cancer |
Saad Alomar, College of Medicine-University of Basra, Iraq | |
12:20-12:40 | Title: Lumpectomy surgery for large ductal carcinoma in situ |
Jacqueline Tsai, Stanford University School of Medicine, USA | |
12:40-13:00 | Title: Entosis in breast cancer as regulated process depending on stage of cancer |
Izabela M?ynarczuk-Bia?y, Warsaw Medical University, Poland | |
Networking & Panel Discussion | |
13:00-13:50 Lunch Break @ Restaurant | |
13:50-14:40 Poster Presentations | |
GICBC-101 | Title: Spermidine potentiates anti-tumor immune responses and immunotherapy sensitivity in breast cancer |
Wenfeng Zeng, Sun Yat Sen University, China | |
GICBC-102 | Title: Case report of synchronous triple primary malignancies: bilateral breast cancer and rectal adenocarcinoma |
Chiaching Yu, Taipei City Hospital, Taiwan | |
GICBC-103 | Title: RGS4 and αSMA-expressing CAFs mediate immune escape via immunosuppressive mesenchymal network formation |
Huiping Chen, Sun Yat Sen University, China | |
GICBC-104 | Title: Application of artificial intellingence in cardio-oncology imaging for canver therapy-related cardiovascular toxicity: systematic review |
Mohammed Hassan A Obaidan, Johns Hopkins Aramco Healthcare/ University College Dublin, Saudi Arabia | |
GICBC-105 | Title: Wild-Type p53 Restrains CIP4 to Suppress Breast Cancer Metastatic Risk |
Sohidul Islam, Academy of Scientific and Innovative Research, India | |
SCIENTIFIC SESSION-IV Session Chairs: Lei Duan, Rush University Medical Center, USA & Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia |
|
14:40-15:00 | Title: Detection of Circulating Tumor Cells by Cell Block Technique in Malignant Tumors |
Jahnvi Vijay, Rajiv Gandhi University of Health Sciences, India | |
15:00-15:20 | Title: A new modality for cancer tracking - Raman imaging, nanoIR imaging, fluorescence and AFM studies combined with AI analysis |
Halina Abramczyk, Lodz University of Technology, Poland | |
15:20-15:40 | Title: An Epigenetics-Plus Combinatorial Therapy That Enables Immune Checkpoint Susceptibility as a Novel Cold-to-Hot Drug. |
Amy S. Yee, Tufts University School of Medicine, USA | |
15:40-16:00 | Title: Synergistic Action of Benzyl Isothiocyanate and Sorafenib in a Nanoparticle Delivery System for Enhanced Triple-Negative Breast Cancer Treatment |
Qi Wang, University of East Anglia, UK | |
16:00-16:20 Refreshment Break | |
16:00-16:20 | Title: Dissecting the Oncogenic Circuitry of miR-99b-5p in Breast Cancer: From Targetome to Tumor Regression |
Bala Gür Dedeoglu, Ankara University, Turkey | |
16:20-16:40 | Title: Expanding theranostics with ultrasound-mediated oncolytic virotherapy: at the crossroads of image guided gene therapy & immunotherapy to combat triple negative breast cancer |
Candace Howard-Claudio, University of Mississippi Medical Center, USA | |
16:40-17:00 | Title: Taking one more innovative step forward. Use of deepithelialized axio-perforator, bipedicled flap for immediate combined breast/nac reconstruction |
Vagif Kalender (Galandarov), Azerbaijan Medical University, Azerbaijan | |
Networking & Panel Discussion | |
Closing Ceremony | |
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org |
Virtual agenda
Day -2: July 08th, 2025 Time Zone: Central European Time (CET) |
|
Virtual Presentations | |
07:45-08:05 | Title: Breast cancer survivors, psychological distress and quality of life: a multifaceted model of healthcare |
Syeda Zakia Hossain, The University of Sydney, Australia | |
08:05-08:25 | Title: Introducing Cosmosort: The Next Generation Spatial Cell Sorter |
Haewook Jang, Meteorbiotech, South korea | |
08:25-08:45 | Title: One stage single port endoscopic breast cancer reconstruction with Bra-flap technique and direct to implant : a four-year case series report of SmoothSilk implant |
Tsung Chun Huang, China Medical University Hospital, Taiwan | |
08:45-09:05 | Title: Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer |
Nan-Haw Chow, China Medical University Hospital, Taiwan | |
09:05-09:25 | Title: Microwave ablation treatment of non-lactating mastitis |
Aili Saiding, Guangyuan Central Hospital, China | |
09:25-09:45 | Title: The identification and potential mechanism of SET7/9 as a tumor biomarker in breast cancer |
Wenzhe Si, Peking University Third Hospital, China | |
09:45-10:05 | Title: CanAssist Breast: First Proteomics and Artificial Intelligence Based Cost-effective Prognostic Test: Real world data |
Manjiri Bakre, OncoStem Diagnostics Pvt Ltd, India | |
10:05-10:15 | Title: SDG like Bioactive Constituent of C. gouriana Exhibits Anticancer Potential in Breast Cancer Cells |
Reena Jassal, Punjabi University, India | |
10:15-10:25 | Title: Comparative Evaluation of Biological Activity of Anti-Breast Cancer Monoclonal Antibodies |
Harish Chander, National Institute of Biologicals, India | |
10:25-10:45 | Title: The impact of bitter taste genes TAS2R38 and CA6 and breast cancer risk |
Dorota Lukasiewicz-Smietanska, National Research Institute, Poland | |
10:45-11:05 | Title: Automatic detecting multiple bone metastases in breast cancer |
Yali Xu, Peking Union Medical College Hospital, China | |
11:05-11:25 | Title: Efficacy and safety of robotic-assisted versus endoscopic-assisted axillary lymph node dissection in node-positive breast cancer: a retrospective comparative study |
Haiyan Li, The Sixth Affiliated Hospital of Sun Yat-sen University, China | |
11:25-11:45 | Title: Factors Influencing Adherence to Endocrine Therapy After Breast Cancer Surgery |
Aina Johnsson, Karolinska Institutet, Sweden | |
11:45-12:05 | Title: Metabolome-Microbiome cross-talk in CRD-induced mammary tumorigenesis |
Tapasree Roy Sarkar, Texas A & M University, USA | |
12:05-12:25 | Title: Radiomics and Machine Learning for Preoperative Differentiation of In Situ and Invasive Breast Cancer Using DCE–MRI |
Luana Conte, University of Palermo, Italy | |
12:25-12:45 | Title: Toll-like Receptor 2-targeted therapies ameliorate the efficacy of chemotherapy and immunotherapy in breast cancer |
Laura Conti, University of Torino, Italy | |
12:45-13:05 | Title: Curcumin and doxorubicin delivered by biocompatible clay-based nanomaterials to overcome multidrug resistance in breast cancer |
Paola Poma, University of Palermo, Italy | |
13:05-13:25 | Title: Sleep, physical activity, and sedentary behaviors in relation to breast cancer risk: results from a case-control study among Polish-born women in the US |
Azam Najaf Kouchak, Michigan State University, USA | |
13:25-13:45 | Title: Identification and characterization of a novel selective HDAC6 inhibitor against triple negative breast cancer |
Elisabetta Panza, University of Naples Federico, Italy | |
13:45-14:05 | Title: How we do it: Songket suture technique for lying half cone dog ear |
Nur Qodir, University of Sriwijaya, Indonesia | |
14:05-14:25 | Title: Novel therapeutic approaches in development for hormone receptor-positive metastatic breast cancer |
Richard Baird, University of Cambridge, UK | |
14:25-14:45 | Title: Optimizing the Patient Experience for Women with Disabilities in the Breast Imaging Clinic |
Jamie Spoont, University of Miami-Miller School of Medicine, USA | |
14:45-15:05 | Title: Multi-modal microscopy for treatment of breast cancer cells with zirconium-based nano-particles |
Herbert Schneckenburger, Aalen University, Germany | |
15:05-15:25 | Title: Toxicity, half-life and antitumor activity of phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates: A novel family of antimitotic CYP1A1-targeted prodrugs in murine models |
Atziri Corin Chavez Alvarez, Inserm-Université Clermont-Auvergne, France | |
15:25-16:05 | Title: Breast Cancer Eradication by Steroid Receptor Coactivator-3 Deleted Regulaotry T Cells |
Sang Jun Han, Baylor College of Medicine, USA | |
16:05-16:25 | Title: Minimally Invasive Breast Cancer: How to Find Early Breast Cancers |
Harnoor Singh, University of Texas at Houston, USA | |
16:25-16:45 | Title: Epigenetic aging phenotype: a tumor biomarker for cancer susceptibility |
Jung Su Yon, University of California, USA | |
16:45-17:05 | Title: TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells |
Stanley Lipkowitz, National Cancer Institute, USA | |
17:05-17:25 | Title: Mammography-based Longitudinal Breast Cancer Risk Prediction Using a Temporal Multi-Modal Feature Fusion Framework |
Haoyan Ding, UCLA, USA | |
Closing Ceremony | |
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org |